Overseas GLP-1s and Peptides: The Grey Market Dangers

Search for GLP-1 medication or peptides online and you will find them for a fraction of what licensed pharmacies charge, often shipped from overseas, frequently with no prescription required. It looks like a bargain. It is one of the riskiest choices in this category, and this article explains why, using what the FDA and researchers have documented.

The short version: when the price is that low, the safeguards that make medication safe are usually missing. You are not buying the same thing for less. You are buying a product nobody has checked, from a seller nobody oversees.

What the “grey market” actually is

The grey market is the space outside the licensed, regulated supply chain. In practice it means overseas online sellers, websites that sell prescription drugs with no prescription, and “research chemical” peptide sites. These sellers are not US-licensed pharmacies, no US state board inspects them, and they do not require a valid prescription.

It also includes a specific label worth naming: products sold “for research purposes” or “not for human consumption.” The FDA has warned companies that illegally sold unapproved drugs containing semaglutide, tirzepatide, retatrutide, survodutide, or mazdutide with those labels, noting that the products were sold directly to consumers for human use with dosing instructions. The FDA urges consumers not to buy them, because they are of unknown quality and may be harmful.^[1] The label does not make the product safer. It tells you nothing about the product was made or tested to a medical standard.

What actually goes wrong

The FDA and independent researchers have documented what happens when those safeguards are missing.

Here is what you cannot verify in a grey-market vial:

• The ingredient. The FDA says counterfeit or illegally marketed semaglutide and tirzepatide could contain the wrong ingredients, harmful ingredients, or too little, too much, or no active ingredient at all.^[1]
• The chemical form. The FDA says some semaglutide products sold by compounders may be salt forms, such as semaglutide sodium or semaglutide acetate. These are different active ingredients from the one in FDA-approved semaglutide products, and the FDA says it is not aware of any lawful basis for using them in compounding.^[1]
• The source of the ingredient. The FDA says some foreign-made GLP-1 active ingredients may be made without appropriate controls to assure quality. It set up a green list import alert (66-80) to help keep GLP-1 active ingredients with potential quality concerns out of the US supply chain.^[1]
• The purity, dose, and sterility. When researchers test-purchased semaglutide from no-prescription websites in a 2024 study, all three vials that arrived were judged probably substandard or falsified. Measured purity was 7.7% to 14.37% against a labeled 99%, the semaglutide content was 28.56% to 38.69% higher than labeled, and bacterial endotoxin was found in every sample.^[2]
• The cold chain. Injectable GLP-1 drugs need refrigeration. The FDA has received complaints of compounded GLP-1 drugs arriving warm or with too few ice packs, and recommends not using any injectable GLP-1 drug that arrives warm or without enough refrigeration.^[1]

Injecting a substance you cannot verify, with no one standing behind it, is not a minor gamble.

The legal and financial reality

The FDA says that in most circumstances it is illegal for individuals to import drugs into the US for personal use, because drugs bought from other countries often have not been approved by the FDA. The FDA can refuse a personal import that is on an import alert, appears to present a serious risk to health, or appears to be health fraud.^[3] The FDA has also issued warning letters to stop the distribution of illegally marketed semaglutide and tirzepatide online.^[1]

If your package is refused, you may be out the money with no recourse. Some sellers take payment and ship nothing: in the 2024 test purchases, none of the three pen orders arrived, which the researchers attributed to non-delivery scams.^[2] No licensed business or regulator stands behind an anonymous overseas vendor.

Peptides: the grey market’s other lane

Everything above applies to the research peptide market too. Many peptides are sold online as “research chemicals,” and the FDA has warned companies selling GLP-1-type molecules this way, including investigational ones such as retatrutide, survodutide, and mazdutide.^[1] The FDA says retatrutide and cagrilintide cannot be used in compounding under federal law, are not components of any FDA-approved drug, and have not been found safe and effective for any condition.^[1]

The “research use only” label is the whole business model, because it lets the seller avoid the obligations that apply to medicines. If you are considering any peptide, where it comes from is not a detail. Talk with a licensed provider before using any peptide, and do not buy one labeled for research.

The alternative is not complicated

The safer path is straightforward. A licensed provider decides whether a prescription is appropriate, and a state-licensed US pharmacy fills it. The FDA recommends getting a prescription and filling it at a state-licensed pharmacy.^[1] You can look up the pharmacy’s license with your state board of pharmacy, search the FDA’s warning letter database for its name, ask whether it is a 503A pharmacy or a 503B outsourcing facility, and ask for the certificate of analysis for your lot.^[4][5]

Compounded medication from a licensed pharmacy is still not FDA-approved, and licensed pharmacies have had recalls and quality problems too (see GLP-1 Recalls and FDA Safety Alerts). What it offers is a license, a record, and someone accountable, which an overseas source does not. For a step-by-step version, use How to Vet a Compounding Pharmacy: A Checklist. For what testing a 503A pharmacy does and does not have to do, read Inside a 503A Pharmacy. For the regulatory facts on compounded semaglutide, see Is Compounded Semaglutide Safe?.

The bottom line

The overseas grey market is cheap because the safeguards are missing: the license, the prescription, the oversight, and the accountability. What you save in dollars you pay for in risk, injecting a product you cannot verify, with no one standing behind it and legal exposure on top. A state-licensed US pharmacy with a valid prescription is the option where you can check who made your medication and ask how it was tested.

What to read next

Start with How to Vet a Compounding Pharmacy: A Checklist for the public checks you can run on any pharmacy, and Inside a 503A Pharmacy for the testing detail. Compounding Pharmacy Profiles and Safety Guides has the rest of this section. To follow current threats, GLP-1 Recalls and FDA Safety Alerts tracks counterfeit warnings and recalls.

Sources

1. U.S. Food and Drug Administration. “FDA’s Concerns with Unapproved GLP-1 Drugs Used for Weight Loss.” Content current as of October 1, 2026. Accessed October 17, 2026. https://www.fda.gov/drugs/drug-alerts-and-statements/fdas-concerns-unapproved-glp-1-drugs-used-weight-loss
2. Ashraf AR, Mackey TK, Vida RG, et al. “Multifactor Quality and Safety Analysis of Semaglutide Products Sold by Online Sellers Without a Prescription: Market Surveillance, Content Analysis, and Product Purchase Evaluation Study.” J Med Internet Res. 2024;26:e65440. doi:10.2196/65440. PMID 39509151. https://pubmed.ncbi.nlm.nih.gov/39509151/
3. U.S. Food and Drug Administration. “Personal Importation.” Content current as of August 18, 2025. Accessed October 17, 2026. https://www.fda.gov/industry/import-basics/personal-importation
4. U.S. Food and Drug Administration. “BeSafeRx: Locate a State-Licensed Online Pharmacy.” Accessed October 17, 2026. https://www.fda.gov/drugs/besaferx-your-source-online-pharmacy-information/locate-state-licensed-online-pharmacy
5. U.S. Food and Drug Administration. “Warning Letters.” Accessed October 17, 2026. https://www.fda.gov/inspections-compliance-enforcement-and-criminal-investigations/compliance-actions-and-activities/warning-letters